Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

# ACTION:

Notice of meeting.

# SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS). This meeting is open to the public.

# DATES:

The meeting will be held on January 22, 2019, 11:00 a.m. to 2:00 p.m., EDT.

# ADDRESSES:

                        Virtual—Summaries of meetings and a roster of Committee members are available on the NCHS BSC website:                         *https://www.cdc.gov/​nchs/​about/​bsc.htm.*

# FOR FURTHER INFORMATION CONTACT:

                        Sayeedha Uddin, M.D., M.P.H., Executive Secretary, NCHS/CDC, Board of Scientific Counselors, 3311 Toledo Road, Room 2627, Hyattsville, Maryland 20782, telephone (301) 458-4303, email                         *isx9@cdc.gov.*

# SUPPLEMENTARY INFORMATION:

                    To join the session go to                     *https://roseliassociates.webex.com/​roseliassociates/​k2/​j.php?​MTID=​tfdddad42079860e7fedf3935962fd22f.*

2. Enter your name and email address (or registration ID).

3. Enter the session password: Jan22.

4. Click “Join Now”.

5. Follow the instructions that appear on your screen.

To join the session by phone only call the number below and enter the access code.

*United States Toll Free:*                     1-844-621-3956.                

*United States Toll (San Jose):*                     +1-240-454-0887.                

*Global call-in numbers: https://roseliassociates.webex.com/​roseliassociates/​globalcallin.php?​serviceType=​TC&​ED=​753000972&​tollFree=​1.*

*Show toll-free dialing restrictions: https://www.webex.com/​pdf/​tollfree_​restrictions.pdf.*

*Access code:*                     647 874 925.                

                    For assistance you can contact Michele Dillon at:                     *michele.dillon@roseliassociates.com,*                     1-301-412-0987.                

                    Can't join the training session?                     *https://collaborationhelp.cisco.com/​article/​qg8vzfb.*

                    To update this session to your calendar program (for example Microsoft Outlook), click this link:                     *https://roseliassociates.webex.com/​roseliassociates/​k2/​j.php?​MTID=​t1946c9546eabdef918f44ebc6b656537*.                

*https://www.webex.com.*

*Purpose:*                     This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS.                

*Matters to be considered:*                     The agenda will include remarks by NCHS leadership; presentation and discussion of the Patient-Centered Outcomes Research Trust Fund Drug Workgroup report. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                     **Federal Register**                     notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                

Sherri Berger,

Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2018-27719 Filed 12-20-18; 8:45 am]

BILLING CODE 4163-19-P